Borderline Resectable Pancreatic Cancer

• CLINICAL_TRIALS research · 2026-03-04
  Clinical Trial Update: EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

  A planned clinical trial uses endoscopic ultrasound-guided circulating tumor cells combined with multi-omics to predict recurrence and metas…

• CLINICAL_TRIALS research · 2026-01-15
  Clinical Trial Update: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating zimberelimab and quemliclustat with chemotherapy for borderline resectable or locally advanced pancreati…

• CLINICAL_TRIALS research · 2025-04-25
  Clinical Trial Update: A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

  This clinical trial outlines a personalized management pathway for locally advanced and borderline resectable pancreatic cancer and is curre…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) [NA]

  The PeRFormanCe trial is exploring diffusion-weighted MRI, radiomics, and liquid biopsy to predict surgical resectability after FOLFIRINOX i…

• CLINICAL_TRIALS research · 2024-07-10
  Clinical Trial Update: Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer [Phase 2]

  A Phase 2 clinical trial evaluating irinotecan liposome II in combination with 5-FU/leucovorin and oxaliplatin for perioperative treatment o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.